Table 2.
Use and withdrawal of fall-risk-increasing drugs (n = 139)
| Baseline use (n = 126) | Number of withdrawals (n = 75) | |||
|---|---|---|---|---|
| Psychotropic drugs | 33 | (26%) | 29 | (39%) |
| Sedatives | 26 | (21%) | 22 | (29%) |
| Antidepressants | 14 | (11%) | 8 | (11%) |
| Neuroleptics | 3 | (2%) | 2 | (3%) |
| Cardiovascular drugs | 62 | (50%) | 41 | (55%) |
| Antihypertensives | 51 | (41%) | 29 | (39%) |
| Nitrates | 15 | (12%) | 5 | (7%) |
| Anti-arrhythmics | 4 | (3%) | 3 | (4%) |
| Nicotinic acid | 1 | (1%) | 1 | (1%) |
| β-adrenoceptor blocker eye drops | 3 | (2%) | 3 | (4%) |
| Other drugs | 41 | (33%) | 18 | (24%) |
| Analgesics | 68 | (54%) | 9 | (12%) |
| Antivertigo preparations | 11 | (9%) | 7 | (9%) |
| Hypoglycaemics | 20 | (16%) | 1 | (1%) |
| Urinary antispasmodics | 4 | (3%) | 1 | (1%) |
In the second column, the baseline usage of FRID for the total study population is shown. In total, 126 patients used 262 fall-risk-increasing drugs (FRID). In the third column, the 91 withdrawn FRID in 75 patients are given, clustered in psychotropic, cardiovascular and other drugs.